Tailored end-to-end services
State-of-the-art cGMP
approved facilities
Experts for every step
Hanmi Pharmaceutical provides the best CDMO service to customers worldwide based on its R&D capabilities and state-of-the-art facilities. Hanmi aims to be the best partner in realizing customer-tailored services through skilled professionals and top-notch facilities. We want to share our experience in
developing and producing products in the fastest and highest quality manner through optimized routes with healthcare companies around the world.
Hanmi Pyeongtaek Bioplant, located in Pyeongtaek, Gyeonggi-do, Korea, manufactures and supplies excellent biopharmaceutical products
worldwide. Through approvals from MFDS and the US FDA, Pyeongtaek Bioplant is supplying commercial biopharmaceutical products to both the US and Korean markets.
Pyeongtaek Bioplant is equipped with state-of-the-art large-scale manufacturing facilities optimized for the commercial production of microbial-based biopharmaceuticals, including bioreactors with a maximum capacity of 12,500 liters. Additionally, the site houses advanced manufacturing facilities for prefilled syringes, capable of producing over 30 million units annually.
NO | Date | Country | Contents |
---|---|---|---|
1 | Aug. 2007 | Republic of Korea / MFDS | MFDS Pre-approval of GMP Plant (PIC/S) |
2 | Nov. 2008 | Republic of Korea / MFDS | MFDS Pre-approval of BGMP |
3 | Jan. 2011 | UK / SGS | Certificate of ISO13485 |
4 | Jun. 2015 | Republic of Korea / Korea Foundation of Quality | Certificate of ISO14001 |
5 | Dec. 2019 | Republic of Korea / Korea Foundation of Quality | Certificate of ISO45001 |
6 | May. 2018 | USA / FDA | Premarket approval application(PMA) for SYNOJOYNT |
7 | Nov. 2019 | Republic of Korea / MFDS | MFDS GMP Compliance approval of API&DP |
8 | Sep. 2022 | USA / FDA | BLA Approval for Rolvedon |
9 | May. 2023 | Republic of Korea / MFDS | Certificate of GMP Compliance of a Biopharmaceuticals Contract Manufacturing Organization |
Hanmi Fine Chemical is an affiliate of Hanmi Pharmaceutical located in Siheung, Gyeonggi-do, Korea. Fine Chemical is expanding its scope beyond small molecule APIs and Incrementally Modified Drug development by entering the CDMO business.
In addition to cGMP production facilities, API mass production capacity, and
systematic GMP operation, Hanmi Fine Chemical has secured advanced development technologies in mRNA (cap analog, etc.) materials, PEG, and peptides through proprietary R&D based on its accumulated experience in new drug development. ‘Customized service’ is available for each step, from process development and analysis method development to GMP production. Regulatory documents and audits required by health authorities are also fully available.
NO | Date | Country | Contents |
---|---|---|---|
1 | May. 2016 | System Korea Certification, Korea Occupational Safety & Health Agency | Renewal of the Safety and Health Management System (ISO 45001, KOSHA-MS) |
2 | Jun. 2016 | System Korea Certification | The Quality Management System certification (ISO 14001) reauthentication |
3 | Dec. 2019 | System Korea Certification | "The Business Continuity Management System certification (ISO 22301) reauthentication" |
4 | Mar. 2023 | Minisry of Employment and Labor | PMS(Process Safety Management) S grade |
Paltan Plant is Hanmi Pharmaceutical's central production base for chemical drugs located in Paltan, Gyeonggi-do, Korea. Paltan Smart Plant can rapidly produce more than 6 billion tablets of chemical drugs annually.
Based on its state-of-the-art system and advanced production process, Paltan Plant was accredited by GMP certification from the most pharmaceutically advanced countries and is currently exporting chemical-finished drugs worldwide. The whole process is equipped with the latest ICT (Information and Communication Technology) technology and 90% of the manufacturing and production process is automated.
NO | Date | Country | Contents |
---|---|---|---|
1 | Jan. 1986 | Republic of Korea / MFDS | MFDS Pre-approval of GMP Plant |
2 | Nov. 2017 | Japan / PMDA | MFDS Pre-approval of GMP Plant |
3 | Jun. 2019 | Russia / MITRF | Certificate of GMP Compliance |
4 | Jan. 2020 | Japan / PMDA | Certificate of GMP Compliance |